Atrogin-1, MuRF-1, and sarcopenia

244Citations
Citations of this article
280Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Sarcopenia is one of the leading causes of disability in the elderly. Despite the growing prevalence of sarcopenia, the molecular mechanisms that control aging-related changes in muscle mass are not fully understood. The ubiquitin proteasome system is one of the major pathways that regulate muscle protein degradation, and this system plays a central role in controlling muscle size. Atrogin-1 and MuRF-1 are two E3 ubiquitin ligases that are important regulators of ubiquitin-mediated protein degradation in skeletal muscle. In this review, we will discuss: (i) aging-related changes to skeletal muscle structure and function; (ii) the regulation of protein synthesis and protein degradation by IGF-1, TGF-β, and myostatin, with emphasis on the control of atrogin-1 and MuRF-1 expression; and (iii) the potential for modulating atrogin-1 and MuRF-1 expression to treat or prevent sarcopenia. © 2012 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Gumucio, J. P., & Mendias, C. L. (2013). Atrogin-1, MuRF-1, and sarcopenia. Endocrine. Humana Press Inc. https://doi.org/10.1007/s12020-012-9751-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free